SiteLock

 

Tyler W. LeBaron

Executive Director

 

"While hydrogen’s antioxidant effects have been the primary focus of hundreds of studies since the 2007 Nature Medicine publication, I’m more intrigued by the studies suggesting that hydrogen regulates various signal transduction pathways. It is not surprising to me that hydrogen has therapeutic potential because we have always been exposed to it. For example, nearly 14 billion years ago, hydrogen was produced by the “Big Bang,” and 3.6 billion years ago the earth's atmosphere was rich in hydrogen gas, which was essential in the genesis of life (e.g. hydrogenases, hydrogenosomes, mitochondria, etc.). Humans developed a symbiotic relationship with hydrogen-producing bacteria. Perhaps the reason that hydrogen has a beneficial biological effect is because we have been exposed to hydrogen gas since the dawn of time. I am extremely interested in knowing the primary targets of hydrogen gas.

Although the exact underlying molecular mechanisms and primary targets of hydrogen remain elusive, hydrogen may regulate these pathways via modifying lipid peroxidation cascades, protein phosphorylations, and gene expressions, resulting in anti-inflammatory, anti-allergy, and potential anti-aging benefits.

Due to the clinical significance of hydrogen, the goal of the science-based nonprofit Molecular Hydrogen Foundation (MHF), is to help advance the research, education, and awareness of hydrogen as a therapeutic medical gas."

Short Bio

Tyler W. LeBaron is the Founder and Executive Director of the science-based nonprofit Molecular Hydrogen Foundation/Institute. His background is in biochemistry and was a 1-year Adjunct Instructor of Physiology. He Interned at Nagoya University in the department of Neurogenetics to research the molecular mechanisms of hydrogen gas on cell signaling pathways. He is a director of the International Hydrogen Standards Association (IHSA) and the International Molecular Hydrogen Association (IMHA). He speaks at Medical conferences in the US for doctors CMEs/CEUs, and at academic biomedical hydrogen symposia and conferences around the world. He is also a member of the Academic Committee of Taishan Institute for Hydrogen Biomedical Research. He collaborates with researchers at home and abroad, and helps advance the education, research, and awareness of hydrogen as a therapeutic medical gas

EDUCATION

Bachelor of Science in Biochemistry

Internship at Nagoya University Japan to research molecular mechanisms of H2. Relevant course work include: Biochemistry, Physiology, Advanced Exercise Physiology, Nutritional Biochemistry, Molecular Cell Biology, Quantitative Chemical Analysis, Biology Analysis Techniques

HONORS/ORGANIZATIONS

  • Member of The American Chemical Society
  • Rotary Leadership Representative Councilor
  • Director of International Molecular Hydrogen Association (IMHA
  • Director of International Hydrogen Standards Association (IHSA)
  • Director of European Institute of Molecular Hydrogen (EIMH)
  • Academic Committee of Taishan Institute for Hydrogen Biomedical Research
  • Member of The American Chemical Society
  • Eagle Scout
  • Rotary Leadership Representative Councilor

TEACHING EXPERIENCE

2011-2013 Tutor Chemistry 481 (Biochemistry)
2012-2013 Tutor Biology 461 (Physiology)
2014-2015 Adjunct Instructor of Physiology at BYU-Idaho
2015-present Faculty of Academy of Comprehensive Integrative Medicine (ACIM)
2015-present Faculty of Age Management Medicine Group (AMMG)

RESEARCH INTERESTS

  • Therapeutic effects of hydrogen gas
  • Free Radical Biology and Medicine
  • Therapeutic effects of electrolyzed reduced water
  • Therapeutic effects of exercise for disease prevention and treatment
  • Biological effects of inorganic nitrates
  • Biological and chemical properties of creatine
  • Vitamins, minerals and nutraceuticals
  • Supplements and ergogenic aids
  • Health, longevity and wellness
  • Physiology, biochemistry and organic chemistry

PRESENTATIONS/ PUBLICATIONS

2017 Tyler W. LeBaron; “Hydrogen: an emerging medical gas with clinical significance” presented at 22nd International Conference of FFC-10th International Symposium of ASFFBC at Harvard Medical School, Boston MA, USA. (Sept. 23, 2017).

2017 Tyler W. LeBaron; “Molecular Hydrogen: from basic and clinical research to sports performance; an overview of the data from recent human studies” presented at the International Hydrogen Industry Development Forum, organized by International Molecular Hydrogen Association (IMHA) in Guangzhou, China (Sept. 14, 2017)

2017 Gao, Q., Song, H., Wang, X.T., Liang, Y., Xi, Y.J., Gao, Y., Guo, Q.J., LeBaron, T., Luo, Y.X., Li, S.C. and Yin, X. Molecular hydrogen increases resilience to stress in mice. Nature publication: Scientific Reports, 7 (2017)

2017 Tyler W. LeBaron; “Hydrogen: signal modulator for disease and inflammation” presented at SOPMED Medical Conference in Colorado Springs, Colorado (June 16th, 2017)

2017 Tyler W. LeBaron; “Hydrogen: A Therapeutic Medical Gas” presented at conference and medical group in Jakarta Indonesia (March 8, 2017)

2016 Tyler W. LeBaron; “Hydrogen Revolution in Industry and Medical Biology” presented at the Korea International Symposium on Hydrogen in Seoul Korea (November 25, 2016)

2016 Tyler W. LeBaron; “Hydrogen: A Small Molecule with Great Clinical Significance” presented at ILADS Annual Scientific Medical Conference on Lyme Disease in Philadelphia, PA (November 5, 2016)

2016 Tyler W. LeBaron; “Hydrogen: an Ageless Molecule of an Aging Society; a Scientific Basis for the Amelioration of Inflammation, Oxidation, and Cellular Degeneration” presented at the 3rd Symposium of Chinese Hydrogen Biomedical Association (SCHBA) in Taian city (September 25, 2016)

2016 Tyler W. LeBaron; “Hydrogen: an explosive molecule with explosive therapeutic effects” presented at the International Hydrogen Industry Development Forum, organized by International Molecular Hydrogen Association (IMHA) in Guangzhou, China (Sept. 9, 2016)

2016 Tyler W. LeBaron; “Hydrogen: A Therapeutic Molecule with Ergogenic Potential” presented at the 6th Hydrogen Medicine Conference in Shenyang, China (July 24, 2016)

2016 Tyler W. LeBaron; “Hidrógeno molecular: La revolución de Salud y el Bienestar, presented at Global Conference in Querétaro Mexico (July 12th, 2016)

2016 Tyler W. LeBaron; “Hydrogen Therapy: ‘Primum non nocere’ a revolution in health and wellness” presented at SOPMED Medical Conference in Salt Lake City, Utah (June 17th, 2016)

2016 Tyler W. LeBaron; “Hydrogen: A Unique and Superior Antioxidant Molecule for Athletes” presented at the International Molecular Hydrogen Symposium in Shanghai (March 20, 2016)

2015 Tyler LeBaron; “Molecular Hydrogen: therapeutic and medical applications” presented at Age Management Medical Group. Las Vegas, Nevada (Dec. 8th, 2015).

2015 Tyler W. LeBaron; “Molecular Hydrogen: therapeutic potential for neurodegenerative diseases” presented at Academy of Comprehensive Integrative Medicine. Orlando, Florida (Oct. 24th, 2015)

2015 Tyler W. LeBaron; “Molecular Hydrogen: therapeutic and medical applications” presented at FIME Medical Expo. Miami, Florida. (Aug. 7th, 2015).

2015 Tyler W. LeBaron; “Molecular Hydrogen: an evolutionary and molecular explanation for its ubiquitous biological effects on eukaryotes” presented at the 2nd Molecular Hydrogen Biomedical Symposium. CPMA Chinese Hydrogen Biomedical Association (June 28, 2015)

2015 Tyler W. LeBaron; “Molecular Hydrogen in America: research, products, media, and awareness” presented at 5th Symposium of Medical Molecular Hydrogen at Nagoya University (March 22, 2015) http://www.med.nagoya-u.ac.jp/neurogenetics/mmh2015/sub_program.html

2014 Meyers, Jonathan K., Tyler W. LeBaron, and David C. Collins. “The Journal of Kitchen Chemistry: A Tool for Instructing the Preparation of a Chemistry Journal Article.” Journal of Chemical Education. http://pubs.acs.org/doi/abs/10.1021/ed400671y

2013 Tyler W. LeBaron; “Changes in Oxidation-Reduction Potential of Aqueous Solutions as a Function of pH and Hydrogen Gas Concentration” The Journal of Kitchen Chemistry 2013. 1. P.12

2013 Tyler W LeBaron; “Estimation of Hydrogen gas Concentration in Aqueous Solutions via Oxidation-Reduction Potential Measurements as a Function of pH” presented at BYU-I Research and Creative Works Conference, April 4, 2013. http://beta.byui.edu/Documents/instructional_development/rcw/2013%20Winter/RCW%20Winter%202013%20%282%29.pdf

2012 Tyler W. LeBaron; Determination of nitrate reduction in the presence of ascorbic acid at facilitative pH (Personal project—preliminary results and specific review presented in 2012).

2012 Tyler W. LeBaron; “Testosterone Booster Recommendation Report” (A critical review of purported supplements) http://scholar.google.com/scholar?q=%22Testosterone+Booster+Recommendation+Report%22&btnG=&hl=en&as_sdt=0%2C13

2011 Tyler W. LeBaron; “Creatine recommendation report” (Review of current work and elucidation of creatine stability with respect to various supplements http://scholar.google.com/scholar?q=%22creatine+recommendation+report%22+&btnG=&hl=en&as_sdt=0%2C13

2010 Tyler W. LeBaron; “Functional Water for the Prevention and Treatment of Disease (A comprehensive literature review)”, presented at BYU-I Research and Creative Works Conference, December 9, 2010. http://emp.byui.edu/PyperB/2010FallUGRC.htm

2010 Tyler W. LeBaron “Alkaline Reduced (electrolyzed) Water enhances time to exhaustion during lactate threshold running”, presented at BYU-I Research and Creative Works Conference, Mar 25, 2010 http://emp.byui.edu/PyperB/2010byuiugrc.htm

MISCELLANEOUS

Besides my passion for hydrogen and health I also enjoy hiking, running (see Athlinks), weightlifting and anything active. Hydrogen helps me to live, laugh, love and learn. Connect with me on LinkedIn and Facebook.